Henry Schein, Inc. (HSIC)

Henry Schein, Inc. (HSIC) is a healthcare company (medical distribution) based in the United States. The share price is $84.28, down 0.80% on the day, which values the company at $9.32B. Price as of 17 Nov 2026, 17:23 UTC, from Yahoo Finance.

Key facts

Share price
$84.28−0.80% today
Market value
$9.32B
P/E ratio
23.1×last 12 months
Forward P/E
14.0×
Funk Score
40/100
Against its own history
About its usual priceusual price $76.72
200-week average
$74.8313% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Henry Schein, Inc. in more detail

HSIC trades at 23.1× its last twelve months' earnings, 14.0× next year's expected earnings, 0.7× sales. Measured against its own history, the price is 10% above what its usual multiples would imply ($76.72) — about its usual price. It sits 13% above its 200-week average of $74.83.

Over the last five fiscal years Henry Schein, Inc. has compounded revenue 5.4% a year, earnings per share 3.0% a year, free cash flow -1.1% a year. Its Funk Score is 40 out of 100 (financial strength 3.3, profitability 4.2, growth 3.3, value 5.2, each out of 10).

In its favour: Share count keeps falling. Worth checking: Debt is growing faster than cash flow.

7 of the superinvestors tracked here hold HSIC, including Andrew Wellington (1.7% of the portfolio), David Einhorn (1.5% of the portfolio), Pat English (1.1% of the portfolio).

Superinvestors holding HSIC

7 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:HSIC vs OSCR (Henry Schein, Inc. vs Oscar Health)HSIC vs TGTX (Henry Schein, Inc. vs TG Therapeutics)HSIC vs MDGL (Henry Schein, Inc. vs Madrigal Pharmaceuticals)HSIC vs GMED (Henry Schein, Inc. vs Globus Medical)HSIC vs BRKR (Henry Schein, Inc. vs Bruker)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Henry Schein, Inc. (HSIC): questions and answers

What is HSIC's P/E ratio?

Henry Schein, Inc. trades at 23.1× its last twelve months' earnings and 14.0× next year's expected earnings. At its fiscal year-ends over the past 18 years the P/E ranged from 14.0× to 27.8×, with a median of 19.8×.

What is HSIC's PEG ratio?

Henry Schein, Inc.'s PEG ratio is 1.69 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Henry Schein, Inc.'s market cap?

Henry Schein, Inc. is valued at $9.32B at a share price of $84.28.

Is HSIC overvalued or undervalued?

Against its own history, HSIC is about its usual price: the price is 10% above the $76.72 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is HSIC above its 200-week moving average?

Yes. HSIC is 12.6% above its 200-week average of $74.83. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Henry Schein, Inc. growing?

Over the last five fiscal years Henry Schein, Inc.'s revenue grew 5.4% a year and its earnings per share 3.0% a year; over ten years revenue grew 2.2% a year.

Cite this page

Funkfolio, “Henry Schein, Inc. (HSIC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/HSIC

Underlying data: Yahoo Finance; company filings with the SEC.